59 related articles for article (PubMed ID: 7937753)
1. Okadaic acid promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting protein phosphatase 2A.
Kong J; Li D; Zhang S; Zhang H; Fu Y; Qian B; Bei C; Tan S; Zhu X
J Cell Biochem; 2020 Jan; ():. PubMed ID: 31904141
[TBL] [Abstract][Full Text] [Related]
2. Low level sequence variant analysis of recombinant proteins: an optimized approach.
Zeck A; Regula JT; Larraillet V; Mautz B; Popp O; Göpfert U; Wiegeshoff F; Vollertsen UE; Gorr IH; Koll H; Papadimitriou A
PLoS One; 2012; 7(7):e40328. PubMed ID: 22792284
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Cardiac PKA Signaling by cAMP and Oxidants.
Cuello F; Herberg FW; Stathopoulou K; Henning P; Diering S
Antioxidants (Basel); 2021 Apr; 10(5):. PubMed ID: 33923287
[TBL] [Abstract][Full Text] [Related]
4. Allyl-Isothiocyanate and Microcystin-LR Reveal the Protein Phosphatase Mediated Regulation of Metaphase-Anaphase Transition in
Garda T; Kónya Z; Freytag C; Erdődi F; Gonda S; Vasas G; Szücs B; M-Hamvas M; Kiss-Szikszai A; Vámosi G; Máthé C
Front Plant Sci; 2018; 9():1823. PubMed ID: 30619398
[TBL] [Abstract][Full Text] [Related]
5. Paxillin phosphorylation at serine 273 and its effects on Rac, Rho and adhesion dynamics.
Tang K; Boudreau CG; Brown CM; Khadra A
PLoS Comput Biol; 2018 Jul; 14(7):e1006303. PubMed ID: 29975690
[TBL] [Abstract][Full Text] [Related]
6. The broken "Off" switch in cancer signaling: PP2A as a regulator of tumorigenesis, drug resistance, and immune surveillance.
Ruvolo PP
BBA Clin; 2016 Dec; 6():87-99. PubMed ID: 27556014
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor activates the Rho GTPase-activating protein (GAP) Deleted in Liver Cancer 1 via focal adhesion kinase and protein phosphatase 2A.
Ravi A; Kaushik S; Ravichandran A; Pan CQ; Low BC
J Biol Chem; 2015 Feb; 290(7):4149-62. PubMed ID: 25525271
[TBL] [Abstract][Full Text] [Related]
8. CREB/TRH pathway in the central nervous system regulates energy expenditure in response to deprivation of an essential amino acid.
Xia T; Zhang Q; Xiao Y; Wang C; Yu J; Liu H; Liu B; Zhang Y; Chen S; Liu Y; Chen Y; Guo F
Int J Obes (Lond); 2015 Jan; 39(1):105-13. PubMed ID: 24732144
[TBL] [Abstract][Full Text] [Related]
9. Regulation of PRDX1 peroxidase activity by Pin1.
Chu KL; Lew QJ; Rajasegaran V; Kung JT; Zheng L; Yang Q; Shaw R; Cheong N; Liou YC; Chao SH
Cell Cycle; 2013 Mar; 12(6):944-52. PubMed ID: 23421996
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling.
Janssens V; Goris J
Biochem J; 2001 Feb; 353(Pt 3):417-39. PubMed ID: 11171037
[TBL] [Abstract][Full Text] [Related]
11. Hamster pancreatic beta cell lines with altered sensitivity towards apoptotic signalling by phosphatase inhibitors.
Krautheim A; Brechlin P; Becker K; Winkler M; Steinfelder HJ
Br J Pharmacol; 2000 Feb; 129(4):687-94. PubMed ID: 10683193
[TBL] [Abstract][Full Text] [Related]
12. Induction of minisatellite mutation in NIH 3T3 cells by treatment with the tumor promoter okadaic acid.
Nakagama H; Kaneko S; Shima H; Inamori H; Fukuda H; Kominami R; Sugimura T; Nagao M
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10813-6. PubMed ID: 9380716
[TBL] [Abstract][Full Text] [Related]
13. Site-directed mutagenesis of amino acid residues of protein phosphatase 1 involved in catalysis and inhibitor binding.
Huang HB; Horiuchi A; Goldberg J; Greengard P; Nairn AC
Proc Natl Acad Sci U S A; 1997 Apr; 94(8):3530-5. PubMed ID: 9108010
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the PP2A alpha gene mutation in okadaic acid-resistant variants of CHO-K1 cells.
Shima H; Tohda H; Aonuma S; Nakayasu M; DePaoli-Roach AA; Sugimura T; Nagao M
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9267-71. PubMed ID: 7937753
[TBL] [Abstract][Full Text] [Related]
15. Analysis by in vitro mutagenesis of PP2A alpha okadaic acid responsive sequences.
Kaneko S; Shima H; Amagasa T; Takagi M; Sugimura T; Nagao M
Biochem Biophys Res Commun; 1995 Sep; 214(2):518-23. PubMed ID: 7677760
[TBL] [Abstract][Full Text] [Related]
16. Protein serine/threonine phosphatases as binding proteins for okadaic acid.
Nagao M; Shima H; Nakayasu M; Sugimura T
Mutat Res; 1995 Dec; 333(1-2):173-9. PubMed ID: 8538625
[TBL] [Abstract][Full Text] [Related]
17. Human leukemia K562 cell mutant (K562/OA200) selected for resistance to okadaic acid (protein phosphatase inhibitor) lacks protein kinase C-epsilon, exhibits multidrug resistance phenotype, and expresses drug pump P-glycoprotein.
Zheng B; Chambers TC; Raynor RL; Markham PN; Gebel HM; Vogler WR; Kuo JF
J Biol Chem; 1994 Apr; 269(16):12332-8. PubMed ID: 7512966
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a human small-cell lung-cancer subline resistant to okadaic acid.
Takeda Y; Nishio K; Kubota N; Miura K; Morikage T; Ohmori T; Kudoh S; Niitani H; Saijo N
Int J Cancer; 1994 Sep; 58(6):882-90. PubMed ID: 7927883
[TBL] [Abstract][Full Text] [Related]
19. Protein serine/threonine phosphatases; an expanding family.
Cohen PT; Brewis ND; Hughes V; Mann DJ
FEBS Lett; 1990 Aug; 268(2):355-9. PubMed ID: 2166691
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
